MINIVISC PLUS 14 mg/ml Fermented Ophthalmic Viscosurgical Device (OVD-F)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for MINIVISC PLUS 14 mg/ml Fermented Ophthalmic Viscosurgical Device (OVD-F), covering 2025-09-19 to 2025-09-19. Get the full timeline:
Most recent: Clinical Trial Update: A Clinical Investigation of MINIVISC® PLUS 14 mg/ml Fermented Ophthalmic Viscosurgical Device (OVD-F), Used for Cataract Surgery and Implantation of Intraocular Lenses, Glaucoma Surgery, Anterior Segment Surgery and Corneal Transplantation (CGAC) [NA]